Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash & Current Investments (2018 - 2026)

Health Catalyst filings provide 9 years of Cash & Current Investments readings, the most recent being $108.8 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 68.18% to $108.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $108.8 million, a 68.18% decrease, with the full-year FY2025 number at $95.7 million, down 75.58% from a year prior.
  • Cash & Current Investments hit $108.8 million in Q1 2026 for Health Catalyst, up from $95.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $425.4 million in Q1 2022 to a low of $91.5 million in Q3 2025.
  • Median Cash & Current Investments over the past 5 years was $343.8 million (2023), compared with a mean of $299.4 million.
  • Biggest five-year swings in Cash & Current Investments: soared 59.67% in 2022 and later crashed 76.36% in 2025.
  • Health Catalyst's Cash & Current Investments stood at $363.5 million in 2022, then decreased by 12.59% to $317.7 million in 2023, then grew by 23.38% to $392.0 million in 2024, then tumbled by 75.58% to $95.7 million in 2025, then grew by 13.67% to $108.8 million in 2026.
  • The last three reported values for Cash & Current Investments were $108.8 million (Q1 2026), $95.7 million (Q4 2025), and $91.5 million (Q3 2025) per Business Quant data.